-
Antimicrob agents ch: "smart" mucus drugs help fight Staphylococcus aureus infection
Time of Update: 2019-12-03
December 4, 2019 / BIOON / -- in a recent study, the authors attempted to use new antibiotics to eliminate fatal staphylococcal infection, and have shown promising results Bacteria can attach to cathe
-
PLoS One: a new method for rapid detection of celiac antibody
Time of Update: 2019-12-02
December 3, 2019 / BIOON / -- recently, researchers at the University of Helsinki developed a novel diagnostic method, called RFs (rapid FRET serum diagnosis), which is used to rapidly measure antibod
-
Structure: a new discovery of antiviral mechanism of bacteria
Time of Update: 2019-12-02
December 3, 2019 / biourn / -- recently, a study led by the University of new Arizona has revealed the structure and function of one of the latest strategies for bacteria to fight against viruses: a "
-
Front immune: big data helps design better influenza vaccine
Time of Update: 2019-12-02
December 1, 2019 / BIOON / -- every year, thousands of Americans get sick from flu, thousands of people are hospitalized or die Influenza vaccination can reduce the chance of infection However, accord
-
December 1 World AIDS Day: interpret the recent research results of HIV heavyweight highlights!
Time of Update: 2019-12-01
December 1, 2019 is the 32nd World AIDS Day; this year, the theme of China's publicity activities is "community mobilization and AIDS prevention, health China I action" According to some data, China h
-
The latest research progress of car-t cell therapy (phase 10)
Time of Update: 2019-11-30
November 30, 2019 / BIOON / -- car-t (chimeric antigen receptor T-cell immunotherapy), i.e chimeric antigen receptor T-cell immunotherapy It is a new cell therapy which has been used in clinic for man
-
New drugs for rare diseases! The risk of recurrence was significantly reduced in the treatment of stage 3 of nmosd with rostralizumab!
Time of Update: 2019-11-30
November 30, 2019 / BIOON / -- Chugai, a Japanese pharmaceutical company controlled by Roche, recently announced the evaluation of McAbs Sakurasky (nct02028884), a global phase III clinical study of s
-
The first Nash drug in the world! Ocaliva (OCA, OBC) has entered the priority review in the United States and will be approved for listing in the first quarter of 2020!
Time of Update: 2019-11-29
November 29, 2019 / BIOON / -- intercept Pharma is a biopharmaceutical company focusing on the development and commercialization of new therapies for the treatment of progressive, non viral liver dise
-
Rare lung disease first drug! A new indication approved by Canada for the treatment of SSC ILD
Time of Update: 2019-11-29
November 29, 2019 / bioun / -- Boehringer Ingelheim, a German pharmaceutical giant, recently announced that Health Canada has approved the oral administration of small molecule tyrosine kinase inhibit
-
First mechanism based septic shock therapy! Nangibotide, a 12 peptide TREM-1 inhibitor, started the global phase IIB research!
Time of Update: 2019-11-28
November 28, 2019 / BIOON / -- inotrem S.A is a biotechnology company specializing in immunotherapy of acute and chronic inflammatory syndrome Recently, the company announced that it has launched the
-
Progress of HIV research highlights in November 2019
Time of Update: 2019-11-27
November 27, 2019 / bioun / - -- human immunodeficiency virus (HIV), or AIDS (acquired immunodeficiency syndrome) virus, is a virus that causes human immune system defects In 1983, HIV was first disco
-
Several articles interpret the recent progress of influenza research!
Time of Update: 2019-11-27
Seasonal influenza viruses cause up to 650000 deaths and 3-5 million severe infections worldwide every year Unconsciously, when winter comes, the flu also comes So how about the recent research progre
-
Many articles focus on the new progress of cancer metabolism research!
Time of Update: 2019-11-27
Recommended meeting of editor: in the 2019 Development Forum of clinical mass spectrometry and high-end medical testing, editor compiled several research results to jointly interpret the new progress
-
Recent progress in the field of intestinal microorganisms!
Time of Update: 2019-11-27
Recommended meeting of editor: in the 2019 Development Forum of clinical mass spectrometry and high-end medical testing, editor collated the recent achievements of scientists in the field of intestina
-
Many articles focus on the new achievements of scientists in the field of T cell research!
Time of Update: 2019-11-27
In this paper, I have compiled several important research results, focusing on the new achievements of scientists in the field of T cell research, and sharing them with you! Photo source: www.pixabay.
-
Nat Microbiol: regulation of norovirus infection by intestinal microorganisms
Time of Update: 2019-11-27
Recommended meeting of editor: 2019 Development Forum of clinical mass spectrometry and high-end medical testing November 27, 2019 news / BIOON / -- highly infectious norovirus can cause diarrhea and
-
The first infliximab hypodermic injection in the world! Remsima SC of celltrion is approved in the EU!
Time of Update: 2019-11-27
November 27, 2019 / BIOON / -- South Korean biopharmaceutical giant celltrion recently announced that the European Commission (EC) has approved remsima SC (ct-p13 SC, infliximab biological analogue) f
-
Pay attention to children's health! These studies are worth reading!
Time of Update: 2019-11-27
In this paper, I have compiled several research reports to jointly interpret the new progress made by scientists in the field of children's health research and share with you! Photo source: www.pixaba
-
Scientists discovered the transcription basis of dendritic cell heterogeneity in mice and human
Time of Update: 2019-11-26
Dendritic cell, also known as DC cell, is a kind of cell which not only has branch or dendritic morphology and phagocytic function, but also can present antigen It can be divided into medullary and ly
-
Multiple sclerosis oral new drug: Bujian tecfidera upgrade product vumerity gastrointestinal tolerance significantly improved!
Time of Update: 2019-11-26
November 26, 2019 / BIOON / -- Biogen recently released detailed data of phase III evolve-ms-2 study of vumerity (diroxime fumarate, biib098) Vumerity is a new oral drug approved by FDA in late Octobe
